Navigation Links
SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention
Date:5/7/2009

Making Elective PCI an Outpatient Procedure to Save Costs Could Put Some Patients at Risk; New Document Guides Physicians in Making Length-of-Stay Decisions

LAS VEGAS, May 7 /PRNewswire/ -- Changes in reimbursement have put pressure on health care facilities to shift more elective percutaneous coronary interventions (PCIs) to "same-day" outpatient procedures. This marked shift could place patients at risk if they are sent home prematurely, and has left physicians without clear guidance as to when such early discharge is appropriate. To help guide physicians in making these decisions, the Society for Cardiovascular Angiography and Interventions (SCAI) has published an expert consensus statement outlining the variables physicians should consider when deciding how long patients should stay in the hospital following an uncomplicated elective PCI. The document, titled "Defining the Length of Stay Following Percutaneous Coronary Intervention," was published online today in Catheterization and Cardiovascular Interventions (CCI; e-publication ahead of print, June 2009, vol. 73, issue 7) and has been endorsed by the American College of Cardiology Foundation.

Elective PCI refers to patients who have stable symptoms but abnormalities in testing that indicate the need for further evaluation by coronary angiography. Depending on the results of the angiogram, some will go on to have a PCI procedure. While short length of stay following an uncomplicated PCI is a key benefit of the procedure, the current standard in the United States is for the patient to remain overnight in a health care facility.

"Because of continued breakthroughs in interventional cardiology, few patients today have to stay in the hospital for two or more days after angioplasty as they did in the past, but it's not always clear which patients should be kept overnight or admitted to the hospital, and which patients can safely return home
'/>"/>

SOURCE Society for Cardiovascular Angiography and Interventions
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. VetCentric Releases Findings of Pet Owner Survey
2. Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus
3. For Medical Device Makers, Full Spectrum Software Releases Software Technology Report Called How to Survive in 2009 and Beyond
4. T-System Releases Free Clinician Swine Flu Templates, Incorporating Updated CDC Interim Guidelines for Diagnosis and Treatment
5. Harvard Medical School Releases Special Health Report on Swine Flu
6. ADA releases position paper on obesity, reproduction and pregnancy outcomes
7. Pennsylvania DEP Releases Evaluation of Air Quality Program
8. PeopleStreme Releases RapidEcho Online Tool for Employee Personal Development
9. MDS Analytical Technologies Releases MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 Cellular Imaging Software
10. International SOS Releases Web Site to Educate Public About Swine Flu Outbreak
11. U.S. Malaria Initiative Releases Third Annual Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... from the Medical College of Wisconsin, in Milwaukee, found ... other sickle cell disease complications in children. Barriers to ... patients were also identified. The study led by ... at the Medical College and Children,s Research Institute at ... the American Society of Hematology meeting Dec. 7, 2009, ...
(Date:12/6/2009)... 6 Sickle cell disease, a condition ... is one of the most common genetic blood ... including more than 70,000 Americans.(1) Research presented today ... Society of Hematology highlights intriguing studies on the ... children with this blood disorder, evaluations of both ...
(Date:12/6/2009)... A new study provides welcome news for patients with ... , The condition is estimated to impact 62,000 ... an abnormal clot forms in a vein and restricts ... some cases, the clot may detach from its point ... lungs, causing a potentially fatal condition known as a ...
(Date:12/6/2009)... of the community, in cooperation with the Greater VA Healthcare System ... This year,s attendance is expected to soar to more than 5,000 ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members ... in West Los Angeles, will once again create a holiday party. ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... Cure(TM) Kicks Off October 1; Join the Breast ... Cancer Movement by Wearing Pink In October, DALLAS, Sept. 25 ... to increase awareness of breast cancer,a disease that without a cure ... can join them. (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ) The celebrities ...
... Can a small-town doctor,with a big idea compete ... exploding personal health records (PHR) arena? Steven M. Hacker ... book Small,Giants where companies choose to be great instead ... and entrepreneur created,PassportMD. The free, Web-based service is growing ...
... survey findings released today indicate that Americans awareness of ... as the tiny nanoscale materials and nano-enabled devices and ... progressing technology that experts believe will usher in a ... that most Americans continue to prefer that government, not ...
... Speaker Nancy Pelosi,issued the following statement today ... Documents are available on the,Administration,s record on fiscal ... our national priorities -- in a fiscally responsible,way, ... "The President has no credibility on matters of ...
... WASHINGTON, Sept. 24 Benjamin England,Special Counsel with ... Rural Development, Food and Drug Administration, and Related,Agencies, ... September,25, 2007 at 10:00 a.m. in Room 2362A ... focus on the on the Food & Drug ...
... ANN ARBOR, Mich. -- Despite decades of advances in ... less likely than whites to have their blood sugar ... new nationally representative study finds. That puts them at ... failure, foot amputation and other long-term diabetes complications. ...
Other Medicine News:Health News:Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure 2Health News:Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure 3Health News:Small Town Doctor Takes on Giants in Consumer Healthcare 2Health News:Poll reveals public awareness of nanotech stuck at low level 2Health News:Poll reveals public awareness of nanotech stuck at low level 3Health News:Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 3Health News:Older blacks and Latinos still lag whites in controlling diabetes 4Health News:Older blacks and Latinos still lag whites in controlling diabetes 5
(Date:12/4/2009)... The U.S. Food and Drug Administration ... an option for the treatment of schizophrenia and manic ... adolescents aged 13-17 years old. ,, The updated ... the increased potential for weight gain and hyperlipidemia in ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
(Date:12/4/2009)... DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC ... has been enrolled in the company,s Phase II-b, dose ... emulsion in traumatic brain injury (TBI). Oxycyte is the ... is of invaluable importance in improving the outcome of ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Texas Hold 26apos 3Bem Tournament to Benefit Autism Speaks 55068 1Texas Hold 26apos 3Bem Tournament to Benefit Autism Speaks 55068 2Texas Hold 26apos 3Bem Tournament to Benefit Autism Speaks 55068 3EndyMed Medical Receives FDA Clearance for Painless Non invasive Anti Wrinkle Treatment System 55066 1EndyMed Medical Receives FDA Clearance for Painless Non invasive Anti Wrinkle Treatment System 55066 2delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 1delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation 9666 2
... with type ... for publication, OWINGS MILLS, Md., Oct. 15 Medifast, ... by researchers at the,Johns Hopkins University Bloomberg School of Public ... is scheduled for,release in an early 2008 issue. The study ...
... Bifantis used appropriate study design to ... demonstrate efficacy compared with placebo, PHILADELPHIA, ... evaluating probiotics in the treatment of irritable bowel,syndrome (IBS) ... in Align(R) (manufactured by Procter & Gamble), is the,only ...
Other Medicine Technology:Medifast, Inc. Announces Acceptance for Publication of Clinical Efficacy Study 2Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms 2Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms 3
... Once your scope arrives, an ... technician makes note of any and ... a thorough customer quote. We respect ... a tight budget so well help ...
... analyzer is the newest addition to the ... reagents, designed to meet the needs of ... laboratories. The Konelab 20XT analyzer has the ... yet improves on the throughput, while providing ...
... is a fully automated, versatile analyzer ... is increased due to the continuous loading ... A fully graphical user interface provides fast ... use. Konelab analyzers are delivered with full ...
Inquire...
Medicine Products: